Resistin levels and inflammatory and endothelial dysfunction markers in obese postmenopausal women with type 2 diabetes mellitus

Table 2 Resistin levels and inflammatory and endothelial markers in T2DM and control women participating to the study

	Control women	All T2DM women	T2DM women without CHD	T2DM women with CHD	P1	P2	Age- adjusted P2
n	55	132	96	36
Resistin(ng/ml)	10.31 ± 4.28	10.27 ± 4.11	9.50 ± 3.33	12.43 ± 5.21	0.953	< 0.001	0.013
hsPCR (mg/L)	2.97 ± 3.27	5.54 ± 6.42	5.83 ± 7.34	4.90 ± 4.55	0.0132	0.452	0.682
IL-6 (pg/ml)	2.17 ± 2.07	2.87 ± 2.07	2.72 ± 3.84	3.35 ± 2.03	0.109	0.317	0.913
sVCAM1 (ng/ml)	715.07 ± 202.63	768.65 ± 313.48	707.32 ± 194.80	940.11 ± 481.97	0.245	< 0.001	0.118
tHcy (μmol/L)	11.47 ± 4.58	12.77 ± 5.94	11.68 ± 5.01	15.92 ± 7.25	0.165	< 0.001	0.799

Data are n, means ± DS
P1: P value for the comparison between T2DM and control women participating to the study
P 2: P value for the comparison between T2DM women with and without CHD

ISSN: 1758-5996